Morgan Stanley Maintains Overweight on Globe Life, Lowers Price Target to $197
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Bob Huang maintains Globe Life (NYSE:GL) with a Overweight and lowers the price target from $208 to $197.
Morgan Stanley analyst Bob Huang maintains Globe Life (NYSE:GL) with a Overweight and lowers the price target from $208 to $197.